Lab Information
Nandini Dendukuri (PhD)
ScientistCentre for Outcomes Research and Evaluation
Department of Medicine (McGill)
Research Profile
http://www.nandinidendukuri.com/
Keywords
Bayesian inference • biostatistics • diagnostic tests • latents class models • technology assessmentResearch Interests
My research focuses on the development of methods in the area of evaluating diagnostic tests in the absence of a gold standard, meta-analysis of diagnostic test properties and Bayesian estimation of small proportions. I am also involved in a number of collaborative projects with researchers in technology assessment and epidemiology.Team Members
| Name | Position |
|---|
Latest Publications
- Olbrich, L., Yang, B., Poore, H., Razid, A., Sweetser, B., Damkjær, M. W., Kay, A. W., Åhsberg, J., Nathavitharana, R. R., Schiller, I., Dendukuri, N., Lundh, A., Shah, M., Bjerrum, S. & Jaganath, D. (2025). Parallel use of low-complexity automated nucleic acid amplification tests on respiratory and stool samples with or without lateral flow lipoarabinomannan assays to detect pulmonary tuberculosis disease in children. The Cochrane database of systematic reviews, vol. 6, p. CD016071.
- Bjerrum, S., Yang, B., Åhsberg, J., Olbrich, L., Damkjær, M. W., Nathavitharana, R. R., Broger, T., Olaru, I. D., Sweetser, B., Poore, H., Razid, A., Kay, A. W., Denkinger, C. M., Schiller, I., Dendukuri, N., Jaganath, D., Lundh, A. & Shah, M. (2025). Parallel use of low-complexity automated nucleic acid amplification tests and lateral flow urine lipoarabinomannan assays to detect tuberculosis disease in adults and adolescents living with HIV. The Cochrane database of systematic reviews, vol. 6, p. CD016070.
- Salimian, S., Hawkins, N. M., Dendukuri, N., Mousavi, N. & Brophy, J. (2025). Predicting death or readmission following heart failure hospitalisation: the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry. Open heart, vol. 12.
- Stahlmann, K., Kellerhuis, B., Reitsma, J. B., Dendukuri, N. & Zapf, A. (2025). Comparison of methods to handle missing values in a continuous index test in a diagnostic accuracy study - a simulation study. BMC medical research methodology, vol. 25, p. 147.
- Kutcher, S. A., Dendukuri, N., Dandona, S., Nadeau, L. & Brophy, J. M. (2025). Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes trial (TC4): a Bayesian pragmatic cluster randomized controlled trial. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, vol. 197, p. E309-E318.
- Li, J., Dendukuri, N., Longtin, Y., Banz, A., Frenette, C., Gervais, P., Miller, M. A., Bourgault, A.--. M., Dawang, N. L. & Loo, V. G. (2025). Determination of the performance of a novel diagnostic test for Clostridioides difficile toxins A and B using latent class analysis. Journal of clinical microbiology, p. e0180724.
- Prosty, C., Le, M., Lu, Y., Khoury, L., Cormier, M., Cheng, M. P., Fowler, R., Murthy, S., Tsang, J. L., Lejtenyi, D., Ben-Shoshan, M., Rahme, E., Golchi, S., Dendukuri, N., Lee, T. C. & Netchiporouk, E. (2024). Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trial. Frontiers in medicine, vol. 11, p. 1437322.
- Verreault-Julien, L., Jahan, I., Dendukuri, N., Ybarra, L. F., Mansour, S., Matteau, A., Wijeysundera, H. C., Fung, A., Robinson, S., Paradis, J.-M., Nguyen, C. M. & Rinfret, S. (2025). Outcomes following antegrade-only versus retrograde chronic total occlusion percutaneous coronary intervention: insights from the CCTOP registry. The Journal of invasive cardiology, vol. 37.
- Couture, S., Frenette, C., Schiller, I., Alfaro, R., Dendukuri, N., Thirion, D., Longtin, Y. & Loo, V. G. (2024). The changing epidemiology of Clostridioides difficile infection and the NAP1/027 strain in two Québec hospitals: a 17-year time-series study. Antimicrobial stewardship & healthcare epidemiology : ASHE, vol. 4, p. e99.
- Le, M., Khoury, L., Lu, Y., Prosty, C., Cormier, M., Cheng, M. P., Fowler, R., Murthy, S., Tsang, J. L. Y., Ben-Shoshan, M., Rahme, E., Golchi, S., Dendukuri, N., Lee, T. C. & Netchiporouk, E. (2024). COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)-a Randomized Controlled Clinical Trial. Open forum infectious diseases, vol. 11, p. ofae102.
See also
